RZLT
RZLT
NASDAQ · Biotechnology

Rezolute Inc

$5.02
+0.23 (+4.80%)
As of Jun 21, 10:29 PM ET ·
Analyst Consensus
Strong Buy
16
Analysts
High
Coverage
Buy 12 75%
Hold 4 25%
Sell 0 0%
Price Target
Analyst Price Target +245.6% upside
Low Target $11.58
Average Target $17.35
High Target $20.59
Current Price $5.02
Current
$5.02
Target
$17.35
$11.58 $17.35 avg $20.59
Scenario Analysis
Bear Case
$11.58
130.7%
Low target
Base Case
$17.35
+245.6%
Avg target
Bull Case
$20.59
+310.2%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$11.46
-56.2% from high
52-Week Low
$1.07
+369.2% from low
Target vs 52W High
$17.35
+51.4% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 78% $257.58 +9.6%
AMGN
Amgen Inc
Hold 44 50% $190.87 -45.9%
GILD
Gilead Sciences Inc
Strong Buy 39 82% $362.68 +188.1%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -8.5%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -87.7%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 37 76% $102.31 -65.9%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -32.0%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -45.4%